Sentences with phrase «breast cancer in women at»

Samuel Broder, director of the National Cancer Institute in the US, said the trial was important because it might demonstrate a «practical method» of preventing breast cancer in women at high risk.

Not exact matches

However, with the exception of women who consumed a high intake of soy during adolescence, the majority of epidemiological studies (studies carried out in defined population groups) have not found that women with higher soy intakes are at lower risk of breast cancer.

A study just published in the journal Lipids in Health and Disease looked at Malaysian women suffering from breast cancer.

Melanie Young (New York, NY)-- Chief Connector and Creative Strategist at The Connected Table, a New York - based public relations and events business, Melanie is a speaker and author of Melanie Young — Getting Things Off My Chest: A Survivor's Guide to Staying Fearless and Fabulous in the Face of Breast Cancer, which provides tips for women on how to manage their diagnosis and stay focused and in charge of their health.

She is the lifestyles editor and writer at a San Francisco Bay Area newspaper and has been a featured blogger for the Huffington Post; columnist for Mommy Tracked: Managing the Chaos of Modern Motherhood, ModernMom.com and Divorce 360; contributor to the anthologies «Nothing But the Truth So Help Me God: 73 Women on Life's Transitions» and «Knowing Pains: Women on Love, Sex and Work in Our 40s,» a fundraiser for breast cancer.

And if breast is best, and if insurance companies have to pay out less money for women and babies who successfully maintain a healthy breastfeeding relationship (this on the assumption that, in fact, breastfed babies and mothers are healthier and less at risk for a variety of chronic ailments or cancers)- wouldn't it be in their best interest to shell out a couple hundred bucks for help their working, nursing mothers maintain a breastfeeding relationship?

We used National Cancer Institute data on the direct costs of invasive breast cancer, which ranged from $ 23,863 for year of diagnosis in women aged 65 years or older to $ 97,490 for the final year of life in women younger than 65 years40 (see Appendix 3, available online at http://links.lww.com/AOG/Cancer Institute data on the direct costs of invasive breast cancer, which ranged from $ 23,863 for year of diagnosis in women aged 65 years or older to $ 97,490 for the final year of life in women younger than 65 years40 (see Appendix 3, available online at http://links.lww.com/AOG/cancer, which ranged from $ 23,863 for year of diagnosis in women aged 65 years or older to $ 97,490 for the final year of life in women younger than 65 years40 (see Appendix 3, available online at http://links.lww.com/AOG/A400).

This particular meta - study reported that breastfeeding provides up to a 28 % decrease in risk of developing breast cancer at any age (pre - or post-menopausal) for women without a family history of the disease, who breastfed for 12 months or longer (World Cancer Research Fund and American Institute for Cancer Research, cancer at any age (pre - or post-menopausal) for women without a family history of the disease, who breastfed for 12 months or longer (World Cancer Research Fund and American Institute for Cancer Research, Cancer Research Fund and American Institute for Cancer Research, Cancer Research, 2007).

A study of nearly 3,000 women conducted by researchers at the University of Buffalo in New York found women who experienced morning sickness during pregnancy were 30 percent less likely to have breast cancer later in life.

One study indicates that breast cancer in the United States could decline by 25 % if all women would breastfeed their children for at least two years.

In a study published in Cancer last year, Phipps and her colleagues found that certain breast cancer types may be rarer among women who breastfeed their babies for at least six monthIn a study published in Cancer last year, Phipps and her colleagues found that certain breast cancer types may be rarer among women who breastfeed their babies for at least six monthin Cancer last year, Phipps and her colleagues found that certain breast cancer types may be rarer among women who breastfeed their babies for at least six mCancer last year, Phipps and her colleagues found that certain breast cancer types may be rarer among women who breastfeed their babies for at least six mcancer types may be rarer among women who breastfeed their babies for at least six months.

«It is a huge reduction in risk,» says Amanda Phipps, a pre-doctoral research associate at the Fred Hutchinson Cancer Research Center in Seattle, of the nearly 60 % decreased risk in women who breastfeed and have a family history of breast cCancer Research Center in Seattle, of the nearly 60 % decreased risk in women who breastfeed and have a family history of breast cancercancer.

«Overall, in the whole group of women we studied, women who had breastfed were 25 % less likely to develop premenopausal breast cancer than women who had never breastfed,» says Stuebe, who conducted the research while at Brigham and Women's Hospital and Harvard Medical School in Bowomen we studied, women who had breastfed were 25 % less likely to develop premenopausal breast cancer than women who had never breastfed,» says Stuebe, who conducted the research while at Brigham and Women's Hospital and Harvard Medical School in Bowomen who had breastfed were 25 % less likely to develop premenopausal breast cancer than women who had never breastfed,» says Stuebe, who conducted the research while at Brigham and Women's Hospital and Harvard Medical School in Bowomen who had never breastfed,» says Stuebe, who conducted the research while at Brigham and Women's Hospital and Harvard Medical School in BoWomen's Hospital and Harvard Medical School in Boston.

A study at the University of Wisconsin found that women who were breast fed in infancy may have a lower risk of developing breast cancer than those who were not breast fed.

Commenting on research, to be published in the July issue of The Oncologist, looking at discrimination in treatment of older women with breast cancer.

In addition, women whose close relatives have had breast cancer, especially at an early age, are more likely to develop breast cancer.

Commenting on research, to be published in the July issue of The Oncologist, looking at discrimination in treatment of older women with breast cancer, Jane Hatfield, Director of Policy and Research at Breast Cancer Care,breast cancer, Jane Hatfield, Director of Policy and Research at Breast Cancer Care,cancer, Jane Hatfield, Director of Policy and Research at Breast Cancer Care,Breast Cancer Care,Cancer Care, said:

Bernard Friedenson, associate professor of biochemistry and molecular genetics at UIC, looked at the DNA sequences of breast cancers from 21 different women and found mutations in genes involved in immunity in every one of them.

During cancer treatments, patients should pay attention not only to their breast health, but also to their general health, including their heart, said Dr. Mehta, who is director of the Women's Cardiovascular Health Program and an associate professor of medicine at The Ohio State University in Columbus, Ohio.

The research team conducted a cross-sectional survey of women who underwent breast cancer surgery for invasive breast cancer or ductal carcinoma in situ at Women & Infants Hospwomen who underwent breast cancer surgery for invasive breast cancer or ductal carcinoma in situ at Women & Infants HospWomen & Infants Hospital.

Among the changes in the American Cancer Society's updated breast cancer screening guideline is that women with an average risk of breast cancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; women 55 years and older should transition to screening every other year (vs annual), but still have the opportunity to continue with annual screening; and routine screening clinical breast examination is no longer recommended, according to an article in the October 20 issue ofCancer Society's updated breast cancer screening guideline is that women with an average risk of breast cancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; women 55 years and older should transition to screening every other year (vs annual), but still have the opportunity to continue with annual screening; and routine screening clinical breast examination is no longer recommended, according to an article in the October 20 issue ofcancer screening guideline is that women with an average risk of breast cancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; women 55 years and older should transition to screening every other year (vs annual), but still have the opportunity to continue with annual screening; and routine screening clinical breast examination is no longer recommended, according to an article in the October 20 issue ofcancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; women 55 years and older should transition to screening every other year (vs annual), but still have the opportunity to continue with annual screening; and routine screening clinical breast examination is no longer recommended, according to an article in the October 20 issue of JAMA.

«It is particularly good news for the large number of affected patients that if they are in good medical care and have survived breast cancer, they do not need to be more worried about deadly heart diseases than women at the same age without breast cancer.»

Steven Narod, director of the Familial Breast Cancer Research Unit at Women's College Research Institution in Toronto, believes that cost and not flawed computer programs are to blame for undertesting.

Razqallah Hakem, a cancer biologist at the University of Toronto in Ontario, and his colleagues normally study a tumor suppressor called BRCA1, variants of which put women at high risk of breast and ovarian cancer.

Extending national breast cancer screening programs to women over the age of 70 does not result in a decrease in the numbers of cancers detected at advanced stages, according to new research from The Netherlands.

Instead, researchers told the European Breast Cancer Conference that their findings suggest that extending screening programs to older women results in a large proportion of women being over-treated, and at risk from the harmful effects of such treatment, because these women were more likely to die from other causes than from any tumors detected in the early stages of growth.

In contrast, an older woman with multiple other diseases or life - limiting conditions, and without any risk factors for breast cancer, will only be at risk of over-diagnosis and overtreatment and may not benefit from screening.»

«A prediction tool should be developed in order to estimate which women are at increased risk of breast cancer and should receive breast cancer screening, instead of screening the whole population.

«Mayo Clinic is now developing new studies that will focus on the role of CDK 4/6 inhibitors and their potential to inhibit cancer metastasis in women with triple - negative breast cancer who are at highest risk for cancer metastasis.»

At least one in 12 women in Britain will develop breast cancer in their lifetime; the vast majority have no family history of the disease.

Women with a family history of two or more immediate family members (mother, sister, daughter) with breast or ovarian cancer or with a positive genetic test for mutations in the BRCA1 or BRCA2 genes may be advised to consider having both breasts removed, because they are at high risk of a new cancer developing in the other breast.

«Instead of only telling women that they don't have cancer, we could test the biopsies and tell women if they were at high risk or low risk for developing breast cancer in the future,» said Polyak, a breast cancer researcher at Dana - Farber and co-senior author of the paper.

«Despite the presence of a universal health insurance system in Ontario, our research highlights the persistence of significant health disparities in breast cancer screening, particularly for women who are more vulnerable due to severe disability, multiple chronic conditions, low income and lower education,» said Dr. Guilcher, who has a PhD in Clinical Epidemiology at the Institute of Health Policy, Management and Evaluation, University of Toronto.

«These are women with advanced metastatic cancer whose disease was kept in check without the use of toxic and life - disrupting chemotherapy,» says Dr. Massimo Cristofanilli, M.D., Director of the Breast Care Center at Thomas Jefferson University and senior author of the study.

«The compelling results seen in this global study provide unequivocal evidence supporting the clinical utility of Oncotype DX to risk - stratify patients with early stage breast cancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medcancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of MedCancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medicine.

The study, published in Cancer, surveyed 1,006 women who were treated for early stage breast cancer and were employed at the time of their diagCancer, surveyed 1,006 women who were treated for early stage breast cancer and were employed at the time of their diagcancer and were employed at the time of their diagnosis.

«Our findings highlight the potential value for a randomized controlled trial of aspirin as an agent in early detection of breast cancer, particularly for women with naturally dense tissues who may be at an increased risk for certain cancers,» said Despina Kontos, PhD, assistant professor of Radiology, and co-author on the study.

For some cancers like breast cancer occurring in younger women before the menopause, there even seemed to be a lower risk at higher BMI.

New American Cancer Society (ACS) breast cancer screening guidelines, and previous data used by the USPSTF to create its recommendations, state that annual screening in women 40 - and - older saves thousands more lives each year than screening at a later age and / or less frequent screCancer Society (ACS) breast cancer screening guidelines, and previous data used by the USPSTF to create its recommendations, state that annual screening in women 40 - and - older saves thousands more lives each year than screening at a later age and / or less frequent screcancer screening guidelines, and previous data used by the USPSTF to create its recommendations, state that annual screening in women 40 - and - older saves thousands more lives each year than screening at a later age and / or less frequent screening.

In a new study published in the American Journal of Medicine, Charles H. Hennekens, M.D., senior author and first Sir Richard Doll Professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University, indicates that black and white women ages 75 to 84 years who had an annual mammogram had lower 10 - year breast cancer mortality than corresponding women who had biennial or no / irregular mammogramIn a new study published in the American Journal of Medicine, Charles H. Hennekens, M.D., senior author and first Sir Richard Doll Professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University, indicates that black and white women ages 75 to 84 years who had an annual mammogram had lower 10 - year breast cancer mortality than corresponding women who had biennial or no / irregular mammogramin the American Journal of Medicine, Charles H. Hennekens, M.D., senior author and first Sir Richard Doll Professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University, indicates that black and white women ages 75 to 84 years who had an annual mammogram had lower 10 - year breast cancer mortality than corresponding women who had biennial or no / irregular mammogramin the Charles E. Schmidt College of Medicine at Florida Atlantic University, indicates that black and white women ages 75 to 84 years who had an annual mammogram had lower 10 - year breast cancer mortality than corresponding women who had biennial or no / irregular mammograms.

Randall Harris, a cancer epidemiologist at Ohio State University, has observed a 68 percent lower risk of lung cancer in heavy smokers who took aspirin regularly; women who took aspirin or ibuprofen for at least five years had a 40 percent lower risk of breast cancer.

Launched in 1993, the Women's Health Initiative halted a Prempro test in July 2002 when researchers discovered that women taking the drug were at a higher risk for developing breast cancer, heart attacks, blood clots, and strWomen's Health Initiative halted a Prempro test in July 2002 when researchers discovered that women taking the drug were at a higher risk for developing breast cancer, heart attacks, blood clots, and strwomen taking the drug were at a higher risk for developing breast cancer, heart attacks, blood clots, and strokes.

For the study, Dr. Hodgson's research team gathered published information from dozens of studies about the risk of developing breast cancer in childhood lymphoma survivors, the accuracy of different forms of breast cancer screening, and the rates at which women agree to be screened when asked.

Recent studies have shown women with cancer in the left breast are at higher risk of heart disease, and that the risk increases proportionately with the dose of radiation the heart is exposed to during treatment.

About 12 percent of women in the United States will battle invasive breast cancer at one point during their lifetime.

Used in conjunction with mammography, imaging based on nuclear medicine is currently being used as a successful secondary screening alongside mammography to reduce the number of false positive results in women with dense breasts and at higher risk for developing breast cancer.

1842 — Domenico Rigoni - Stern looks at the patterns of disease in his hometown of Verona and notices that nuns get cervical cancer less often and breast cancer more often than married women.

A team including scientists at The Institute of Cancer Research, London, found that women whose breast cancer had begun to spread and who tested positive in the αB - crystallin test were three times more likely to have disease that spread to the brain than those who tested negCancer Research, London, found that women whose breast cancer had begun to spread and who tested positive in the αB - crystallin test were three times more likely to have disease that spread to the brain than those who tested negcancer had begun to spread and who tested positive in the αB - crystallin test were three times more likely to have disease that spread to the brain than those who tested negative.

A group of researchers at the University of Helsinki in Finland thought NQO1 could also be a promising predictor of survival for women with breast cancer.

Researchers at the NCI expect the incidence of breast cancer will be reduced by about one - third in the 8000 women receiving the drug.